Cafepharma Today

March 24 2025 - Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
23andMe files for bankruptcy, Anne Wojcicki steps down as CEO
Biogen plots 2028 headquarters shift to new 'innovation hub' in Cambridge
Pharmaceutical supply chain headed for $5.3B valuation
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Fierce Biotech
Monday, March 24, 2025 - 11:20am
tags:
Novo Nordisk, obesity, United Laboratories, triple G agonists, UBT251
23andMe files for bankruptcy, Anne Wojcicki steps down as CEO
CNBC
Monday, March 24, 2025 - 11:18am
tags:
23andMe, bankruptcy, Anne Wojcicki, Medtech, diagnostics
Mira seeks to buy Skny for its preclinical obesity, smoking cessation asset
Fierce Biotech
Monday, March 24, 2025 - 11:08am
tags:
Mira Pharmaceuticals, M&A, Skny Pharmaceuticals, obesity, smoking cessation
Biogen plots 2028 headquarters shift to new 'innovation hub' in Cambridge
Fierce Pharma
Monday, March 24, 2025 - 11:07am
tags:
Biogen, headquarters, Cambridge, Massachusetts
Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy
Fierce Pharma
Monday, March 24, 2025 - 11:05am
tags:
Novo Nordisk, Wegovy, NovoCare Pharmacy, obesity
Elypta’s urine test identifies 90% of recurrent kidney cancer cases
Clinical Trials Arena
Monday, March 24, 2025 - 11:03am
tags:
Elypta, diagnostics, kidney cancer
Brazil's Hypera to launch an Ozempic generic in 2026, CEO says
MSN/Reuters
Monday, March 24, 2025 - 11:02am
tags:
Hypera Pharma, semaglutide, generics, Ozempic, Novo Nordisk
Pharmaceutical supply chain headed for $5.3B valuation
Yahoo Finance
Monday, March 24, 2025 - 11:00am
tags:
pharma industry, supply chain
Lilly, Novo expand DTC reach of obesity meds after compound win
Pharma Voice
Monday, March 24, 2025 - 10:58am
tags:
Eli Lilly, Novo Nordisk, obesity, DTC, Mounjaro, Wegovy
Phase 3 readout puts Opthea at risk of insolvency
Pharmaphorum
Monday, March 24, 2025 - 10:57am
tags:
Opthea, clinical trials, wet age-related macular degeneration, sozinibercept
MIT team develops 'years-long' drug delivery tech
Pharmaphorum
Monday, March 24, 2025 - 10:56am
tags:
MIT, drug delivery
Chimerix engaged with 7 other biopharmas before choosing Jazz’s $935M deal—here’s why it won
Fierce Biotech
Sunday, March 23, 2025 - 11:45pm
tags:
Jazz Pharma, Chimerix, M&A
FDA rejects Hengrui, Elevar's PD-1 cancer drug combination—again
Fierce Pharma
Sunday, March 23, 2025 - 11:43pm
tags:
Jiangsu Hengrui, Elevar Therapeutics, camrelizumab, FDA, cancer
Trump Allies Aim to Slash Drug Prices. The Pharma Industry Is in a Bind.
Barron's
Sunday, March 23, 2025 - 11:41pm
tags:
Donald Trump, drug pricing
Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
Yahoo/Reuters
Friday, March 21, 2025 - 11:42am
tags:
gene therapy, rare disease, cancer, obesity, weight loss, drug development
MacroGenics pulls plug on vobra duo ADC after seeing phase 2 prostate cancer data
Fierce Biotech
Friday, March 21, 2025 - 11:39am
tags:
Macrogenics, vobra duo, clinical trials
Potential impacts of the US withdrawal from the WHO on clinical trials globally
Clinical Trials Arena
Friday, March 21, 2025 - 11:38am
tags:
clinical trials, WHO, Public Health
Eisai's abandoned Enhertu challenger set to live on at BlissBio
Fierce Biotech
Friday, March 21, 2025 - 11:34am
tags:
Eisai, BB-1701, Bliss Bio, liquid biopsy
AstraZeneca details $2.5B investment in China's political center, funding R&D center, biotech pacts
Fierce Biotech
Friday, March 21, 2025 - 11:29am
tags:
AstraZeneca, R&D, China
J&J boosts investments in U.S. to more than $55 billion amid looming tariff threats
CNBC
Friday, March 21, 2025 - 11:27am
tags:
JNJ, drug manufacturing, tariffs

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

Informa Connect’s Life Sciences Pricing & Contracting USA
Drug Channels
Metamorphine, An Unwelcome Product
In the Pipeline
The End of the Blockbuster Era: Unlocking Growth with Direct-to-Patient Commercialization
Drug Channels
A New Type of Antifungal
In the Pipeline
The Continuing Crisis, Part IX: Inside the NIH Now
In the Pipeline
NOW AVAILABLE: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels
How Much Does Math Help Chemistry Students?
In the Pipeline
The Continuing Crisis, Part VIII: mRNA Vaccines Under Attack
In the Pipeline
Direct-to-Consumer Models: Why They’re Expanding and Where They Deliver the Most Impact
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.